KING OF PRUSSIA, Pa., June 13, 2017 /PRNewswire/ -- Greenphire, the global leader in clinical trial payment automation,
The Global Healthcare CRO industry is expected to reach $45.2 billion by 2022, according to a new report by Grand View Research Inc. As this market continues to expand, CROs are looking for ways to differentiate and gain a competitive edge. Technology that empowers CROs to attract and retain top performing sites while delivering more efficient services is critical in this competitive environment.
"We have found that the needs of our CRO clients vary significantly based on size, specialization and region," said Jim Murphy, CEO of Greenphire. "As our clinical payment solutions evolve, we are committed to ensuring that CROs have the tools necessary to efficiently support any trial, regardless of sponsor, geography or technical requirements."
The demands for payment automation are growing. Monthly payments, financial transparency, streamlined invoice management, and increasing global compliance standards are putting more pressure on CROs. Even if a CRO has assembled a dedicated payments team, technology is critical to optimizing and automating the fragmented and manual payment process.
"We have seen a significant increase in demand across the CRO community for our payment solutions to support a better trial experience for both sites and patients," said David Espenshade, VP of CRO Partnerships at Greenphire. "This advisory group will serve as a forum for CROs to collaborate and understand how to truly take advantage of the automation opportunity with a best-in-class solution, without sacrificing quality or competitive edge."
CROs can learn more about the Advisory Group, as well as Greenphire's best-in-class site and patient payment solutions, at DIA, Booth 801, from June 18-22 in Chicago. Contact Greenphire's VP of CRO Partnerships, Dave Espenshade, [email protected] to schedule a meeting.
About Greenphire Greenphire is the global leader in clinical trial payment automation. Greenphire is exclusively focused on optimizing clinical trial performance by streamlining payment processes from sponsors and CROs to sites and patients. The choice of industry leaders worldwide, Greenphire supports site centricity and sustainability, increases patient engagement and retention, and provides more comprehensive financial data, resulting in better trials. Learn more at www.greenphire.com.
Media Contact:Kathleen Fusco(267) [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/greenphire-continues-commitment-to-cro-empowerment-with-new-payments-advisory-group-300472968.html
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...View All